I certainly take this as clearly positive news; at least for me, it wasn’t a “foregone conclusion” that we wouldn’t end up in the FDA pipeline, as the company had communicated cautiously regarding the matter.
There are some quite interesting times ahead timing-wise; commercial prospects are developing on all continents but they take time… they could start materializing in parallel, which could lead to quite a ketchup bottle effect 
Well, let’s not get ahead of ourselves. Today, attention is also on that Sitra seminar to see if anything is heard regarding the domestic side…